Renaissance Technologies LLC Increases Stock Position in Paysign, Inc. (NASDAQ:PAYS)

Renaissance Technologies LLC grew its stake in shares of Paysign, Inc. (NASDAQ:PAYS - Free Report) by 11.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,501,622 shares of the company's stock after buying an additional 149,200 shares during the period. Renaissance Technologies LLC owned approximately 2.80% of Paysign worth $4,535,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of PAYS. Wells Fargo & Company MN grew its position in shares of Paysign by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 15,385 shares of the company's stock valued at $46,000 after purchasing an additional 5,243 shares during the period. SG Americas Securities LLC boosted its holdings in shares of Paysign by 33.5% in the fourth quarter. SG Americas Securities LLC now owns 15,508 shares of the company's stock valued at $47,000 after buying an additional 3,895 shares during the period. Virtu Financial LLC bought a new stake in shares of Paysign during the fourth quarter worth $78,000. Bard Associates Inc. raised its holdings in shares of Paysign by 19.7% during the fourth quarter. Bard Associates Inc. now owns 33,450 shares of the company's stock worth $101,000 after acquiring an additional 5,497 shares during the period. Finally, Rhumbline Advisers lifted its position in Paysign by 13.7% in the 4th quarter. Rhumbline Advisers now owns 44,284 shares of the company's stock valued at $134,000 after acquiring an additional 5,339 shares in the last quarter. Institutional investors own 25.89% of the company's stock.

Analyst Ratings Changes

PAYS has been the topic of several research reports. Barrington Research restated an "outperform" rating and issued a $7.00 target price on shares of Paysign in a research note on Wednesday, March 26th. DA Davidson reiterated a "buy" rating and issued a $6.00 price target on shares of Paysign in a research note on Wednesday, March 26th.

Paysign Stock Performance

Shares of PAYS stock traded down $0.13 on Friday, hitting $2.28. The company had a trading volume of 106,367 shares, compared to its average volume of 208,014. Paysign, Inc. has a twelve month low of $1.80 and a twelve month high of $5.59. The firm has a market cap of $122.71 million, a P/E ratio of 15.20 and a beta of 0.77. The stock's 50-day moving average is $2.35 and its two-hundred day moving average is $2.94.

Paysign (NASDAQ:PAYS - Get Free Report) last released its quarterly earnings results on Tuesday, March 25th. The company reported $0.02 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The firm had revenue of $15.61 million during the quarter, compared to analyst estimates of $15.42 million. Equities research analysts predict that Paysign, Inc. will post 0.21 EPS for the current year.

Insider Buying and Selling

In related news, CEO Mark Newcomer sold 100,000 shares of the business's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $2.73, for a total value of $273,000.00. Following the transaction, the chief executive officer now directly owns 8,936,886 shares of the company's stock, valued at approximately $24,397,698.78. The trade was a 1.11 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 22.40% of the stock is owned by corporate insiders.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.